DR. CRAIG J GERARD, MD, PHD
Osteopathic Medicine at Longwood Ave, Boston, MA
License number
Massachusetts 57118
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
300 Longwood Ave, Boston, MA 02115
Phone
(617) 355-1900
(617) 730-0084 (Fax)
(617) 232-0290
(617) 730-0084 (Fax)
(617) 232-0290
Professional information
Professor At Children's Hospital, Harvard Medical School
Position:
Professor at Children's Hospital, Harvard Medical School
Location:
Greater Boston Area
Industry:
Hospital & Health Care
Work:
Children's Hospital, Harvard Medical School
since Jul 2003
-
Professor
Education:
staples hs
Skills:
Molecular Biology, Genetics, Bioinformatics, Lifesciences, Cancer, Biochemistry, Immunology, Cell Culture, Neuroscience, Cell Biology, Biotechnology, Cell, Drug Discovery, Clinical Research, PCR, Protein Chemistry, Microbiology, Pharmacology
Dr At Harvard University
Position:
dr at Harvard University
Location:
Greater Boston Area
Industry:
Hospital & Health Care
Work:
Harvard University
-
dr
Professor At Harvard University
Position:
Professor at Harvard University
Location:
Greater Boston Area
Industry:
Higher Education
Work:
Harvard University
-
Professor
Craig J Gerard, Boston MA
Specialties:
Internist
Address:
300 Longwood Ave, Boston, MA 02115
Education:
Wake Forest University, School of Medicine - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
Dr. Craig J Gerard, Boston MA - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
Children's Hospital, Boston
300 Longwood Ave, Boston 02115
(617) 355-6369 (Phone), (617) 730-0246 (Fax)
300 Longwood Ave, Boston 02115
(617) 355-6369 (Phone), (617) 730-0246 (Fax)
Certifications:
Internal Medicine, 1988
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Education:
Medical School
Wake Forest University School Of Medicine, Medical Center Boulevard
Graduated: 1985
Beth Israel Hospital
Wake Forest University School Of Medicine, Medical Center Boulevard
Graduated: 1985
Beth Israel Hospital
Craig John Gerard, Boston MA
Specialties:
Internal Medicine, Pulmonary Disease, Adult Medicine
Work:
Children's Hospital Boston
300 Longwood Ave, Boston, MA 02115
300 Longwood Ave, Boston, MA 02115
Education:
Wake Forest University (1985)
Method For Determining Predisposition To Pulmonary Infection
US Patent:
2012012, May 17, 2012
Filed:
Nov 15, 2011
Appl. No.:
13/296557
Inventors:
Hara Levy - Bayside WI, US
Craig Gerard - Chestnut Hill MA, US
Gerald Pier - Brookline MA, US
Scott Weiss - Chestnut Hill MA, US
Christoph Lange - Cambridge MA, US
Craig Gerard - Chestnut Hill MA, US
Gerald Pier - Brookline MA, US
Scott Weiss - Chestnut Hill MA, US
Christoph Lange - Cambridge MA, US
International Classification:
A61K 39/395, A61P 31/04, A61P 29/00, A61P 31/00, A61K 38/16, A61K 31/555
US Classification:
4241341, 514 11, 514184
Abstract:
Provided herein are methods and materials for diagnosing a subject's predisposition for pulmonary infection in a CF subject by detecting a pulmonary infection genetic marker. Pulmonary infection markers have been identified in the IL-1 gene cluster and may be useful in predicting CF disease progression and assessing a CF subject's response to therapy.
Method For Determining Predisposition To Pulmonary Infection
US Patent:
8080394, Dec 20, 2011
Filed:
Apr 28, 2008
Appl. No.:
12/111064
Inventors:
Hara Levy - Bayside WI, US
Craig Gerard - Chestnut Hill MA, US
Gerald Pier - Brookline MA, US
Scott Weiss - Chestnut Hill MA, US
Christoph Lange - Cambridge MA, US
Craig Gerard - Chestnut Hill MA, US
Gerald Pier - Brookline MA, US
Scott Weiss - Chestnut Hill MA, US
Christoph Lange - Cambridge MA, US
Assignee:
Brigham and Women's Hospital - Boston MA
Children's Medical Center Corporation - Boston MA
President and Fellows of Harvard College - Cambridge MA
Children's Medical Center Corporation - Boston MA
President and Fellows of Harvard College - Cambridge MA
International Classification:
C12P 19/34
US Classification:
435 912
Abstract:
Provided herein are methods and materials for diagnosing a subject's predisposition for pulmonary infection in a CF subject by detecting a pulmonary infection genetic marker. Pulmonary infection markers have been identified in the IL-1 gene cluster and may be useful in predicting CF disease progression and assessing a CF subject's response to therapy.